These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 37052747)

  • 1. HIV self-testing: what GetaKit can tell us about Canada's $8 million one-time investment.
    O'Byrne P; Musten A
    Can J Public Health; 2023 Oct; 114(5):867-871. PubMed ID: 37052747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. At-home HIV self-testing during COVID: implementing the GetaKit project in Ottawa.
    O'Byrne P; Musten A; Orser L; Inamdar G; Grayson MO; Jones C; Francoeur M; Lachance S; Paulin V
    Can J Public Health; 2021 Aug; 112(4):587-594. PubMed ID: 33999399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted HIV Self-Testing Identifies Persons with Undiagnosed HIV and Active Engagement Links them to Care: The GetaKit Study.
    O'Byrne P; Kroch A; Orser L; Ho N; Musten A; Haines M; Lindsay J
    AIDS Behav; 2024 Jun; 28(6):2015-2022. PubMed ID: 38526637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV self-testing in Ottawa, Canada used by persons at risk for HIV: The GetaKit study.
    O'Byrne P; Musten A; Vandyk A; Ho N; Orser L; Haines M; Paulin V
    Can Commun Dis Rep; 2021 Oct; 47(10):435-441. PubMed ID: 34737676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV self-testing enabled access to testing for Black persons: The GetaKit study.
    O'Byrne P; Musten A; McCready L; Robinson R; Durrant G; Tigert J; Orser L
    Res Nurs Health; 2023 Apr; 46(2):236-241. PubMed ID: 36573589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP Users.
    Grace D; Jollimore J; MacPherson P; Strang MJP; Tan DHS
    AIDS Patient Care STDS; 2018 Jan; 32(1):24-30. PubMed ID: 29185801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community perspectives on addressing and responding to HIV-testing, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) among African, Caribbean and Black (ACB) people in Ontario, Canada.
    Etowa J; Tharao W; Mbuagbaw L; Baidoobonso S; Hyman I; Obiorah S; Aden M; Etowa EB; Gebremeskel A; Kihembo M; Nelson L; Husbands W
    BMC Public Health; 2022 May; 22(1):913. PubMed ID: 35525946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing a social network approach to promote HIV self-testing and linkage to care among fishermen at Lake Victoria: study protocol for the Owete cluster randomized controlled trial.
    Sheira LA; Kwena ZA; Charlebois ED; Agot K; Ayieko B; Gandhi M; Bukusi EA; Thirumurthy H; Camlin CS
    Trials; 2022 Jun; 23(1):463. PubMed ID: 35668499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions, motivations, and beliefs about HIV risk and pre-exposure prophylaxis (PrEP) among participants in a nurse-led PrEP service (PrEP-RN).
    Orser L; O'Byrne P; Holmes D
    BMC Infect Dis; 2022 Feb; 22(1):196. PubMed ID: 35227202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of HIV pre-exposure prophylaxis among urban Canadian gay, bisexual and other men who have sex with men: a cross-sectional analysis of the Engage cohort study.
    Cox J; Apelian H; Moodie EEM; Messier-Peet M; Hart TA; Grace D; Moore DM; Lachowsky NJ; Armstrong HL; Jollimore J; Skakoon-Sparling S; Rodrigues R; Tan DHS; Maheu-Giroux M; Noor SW; Lebouché B; Tremblay C; Olarewaju G; Lambert G;
    CMAJ Open; 2021; 9(2):E529-E538. PubMed ID: 34021010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinic-Integrated Smartphone App (JomPrEP) to Improve Uptake of HIV Testing and Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Malaysia: Mixed Methods Evaluation of Usability and Acceptability.
    Shrestha R; Altice FL; Khati A; Azwa I; Gautam K; Gupta S; Sullivan PS; Ni Z; Kamarulzaman A; Phiphatkunarnon P; Wickersham JA
    JMIR Mhealth Uhealth; 2023 Feb; 11():e44468. PubMed ID: 36795465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India.
    Kazemian P; Costantini S; Kumarasamy N; Paltiel AD; Mayer KH; Chandhiok N; Walensky RP; Freedberg KA
    Clin Infect Dis; 2020 Feb; 70(4):633-642. PubMed ID: 30921454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canada's international response to HIV during times of global transition: a qualitative inquiry.
    Nixon S
    Curr HIV Res; 2011 Apr; 9(3):194-201. PubMed ID: 21457132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-exposure Prophylaxis Awareness Among Gay and Other Men who have Sex with Men in Vancouver, British Columbia, Canada.
    Lachowsky NJ; Lin SY; Hull MW; Cui Z; Sereda P; Jollimore J; Rich A; Montaner JS; Roth EA; Hogg RS; Moore DM
    AIDS Behav; 2016 Jul; 20(7):1408-22. PubMed ID: 26884310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaching transgender populations in Zambia for HIV prevention and linkage to treatment using community-based service delivery.
    Mwango L; Toeque MG; Lindsay B; Tembo K; Sakala H; Reggee S; Malunga SM; Kabwe M; Kafunda I; Olufunso A; Mwila A; Okuku J; Kancheya N; Nkwemu K; Mumba D; Hachaambwa L; Sheneberger R; Blanco N; Lavoie MC; Stafford KA; Claassen CW
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25995. PubMed ID: 36225155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient perspectives on the role of nurses in HIV pre-exposure prophylaxis care (PrEP-RN).
    Orser L; O'Byrne P; Holmes D
    PLoS One; 2023; 18(7):e0288283. PubMed ID: 37467214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cohort profile: l'Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada.
    Greenwald ZR; Maheu-Giroux M; Szabo J; Robin JAB; Boissonnault M; Nguyen VK; Thomas R
    BMJ Open; 2019 Jun; 9(6):e028768. PubMed ID: 31248931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, non-inferiority, implementation trial.
    Ngure K; Ortblad KF; Mogere P; Bardon AR; Thomas KK; Mangale D; Kiptinness C; Gakuo S; Mbaire S; Nyokabi J; Mugo NR; Baeten JM
    Lancet HIV; 2022 Jul; 9(7):e464-e473. PubMed ID: 35777410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons.
    Springer SA; Nijhawan AE; Knight K; Kuo I; Di Paola A; Schlossberg E; Frank CA; Sanchez M; Pankow J; Proffitt RP; Lehman W; Pulitzer Z; Thompson K; Violette S; Harding KK;
    BMC Infect Dis; 2022 Apr; 22(1):380. PubMed ID: 35428213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.